title: HSP90 and TLR4 Interplay in Keloids.
authors.affiliation: Department of Plastic, Reconstructive and Aesthetic Surgery, "Campus Bio-Medico di Roma" University, Rome, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Segreto
authors.forename: Giovanni Francesco
authors.initials: GF
authors.lastname: Marangi
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Gigliofiorito
authors.forename: Francesca
authors.initials: F
authors.lastname: Briganti
authors.forename: Paolo
authors.initials: P
authors.lastname: Persichetti
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D016227:Benzoquinones / Q000494:pharmacology*; D002465:Cell Movement / Q000187:drug effects*; D005347:Fibroblasts / Q000187:drug effects*; D018841:HSP90 Heat-Shock Proteins / Q000378:metabolism*; D006801:Humans; D007627:Keloid / Q000378:metabolism*; D047029:Lactams, Macrocyclic / Q000494:pharmacology*
chemical_list: D016227:Benzoquinones; D018841:HSP90 Heat-Shock Proteins; D047029:Lactams, Macrocyclic
references.citation: Yun IS, Lee MH, Rah DK, Lew DH, Park JC, Lee WJ. Heat shock protein 90 inhibitor (17-AAG) induces apoptosis and decreases cell migration/motility of keloid fibroblasts. Plast Reconstr Surg. 2015;136:44e–53e
references.citation: Chen J, Zeng B, Yao H, Xu J. The effect of TLR4/7 on the TGF-β-induced Smad signal transduction pathway in human keloid. Burns. 2013;39:465–472
references.citation: Bhattacharyya S, Kelley K, Melichian DS, et al. Toll-like receptor 4 signaling augments transforming growth factor-β responses: A novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am J Pathol. 2013;182:192–205
references.citation: Thuringer D, Hammann A, Benikhlef N, et al. Transactivation of the epidermal growth factor receptor by heat shock protein 90 via Toll-like receptor 4 contributes to the migration of glioblastoma cells. J Biol Chem. 2011;286:3418–3428
references.citation: O’Neill S, Ross JA, Wigmore SJ, Harrison EM. The role of heat shock protein 90 in modulating ischemia-reperfusion injury in the kidney. Expert Opin Investig Drugs. 2012;21:1535–1548